Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Verona Pharma

23 Oct 2020 17:30

RNS Number : 0995D
FTSE Russell
23 October 2020
 

 

 

 

 

Verona Pharma (UK): Constituent DeletionChanges in FTSE UK Index Series

23 October 2020

Subject to the expected cancellation of trading on AIM for Verona Pharma (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

30 October 2020

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSXXLFLBBLEFBK
Date   Source Headline
5th Jan 201210:42 amPRNResult of General Meeting
8th Dec 20112:05 pmPRNCompletion of GBP3.25 million placing
25th Nov 20113:55 pmPRNHolding(s) in Verona Pharma
10th Nov 20117:00 amPRNPositive results for COPD pilot study
3rd Nov 20117:00 amPRNWH Ireland Limited appointed as Nomad and Broker
20th Sep 20117:00 amPRNIssue of Options
7th Sep 20117:01 amPRNInterim Report for the six months ended 30 June 2011
7th Sep 20117:00 amPRNVRP700 demonstrates significant anti-tussive effects
17th Aug 20117:22 amPRNBronchodilation in asthmatics maintained with RPL554
7th Jun 20114:21 pmPRNDirector Options
3rd Jun 20113:43 pmPRNResult of AGM
3rd Jun 201111:09 amPRNAGM Statement
12th May 20117:00 amPRNStart of New Phase II Clinical Trial of RPL554
9th May 20115:29 pmPRNCorrection of AGM date
9th May 20114:13 pmPRNNotice of AGM and Issue of Annual Report
21st Apr 20117:00 amPRNAppointment of Joint Broker
12th Apr 20117:00 amPRNFirst COPD Trial with RPL554 Begins in Rome
23rd Mar 20117:00 amPRNPreliminary Unaudited Results
1st Mar 201110:24 amPRNTotal Voting Rights
22nd Feb 20111:24 pmPRNIssue of Equity
22nd Feb 20117:02 amPRNVerona Pharma announces positive results for RPL554
7th Jan 20117:00 amPRNResponse to Share Price Movement
26th Nov 20107:01 amPRNRPL554: PoC studies on industry-standard inhaler devices
26th Nov 20107:00 amPRNNew Higher Dose RPL554 Clinical Trial in Asthma
27th Oct 20107:00 amPRNVRP700 for chronic cough enters clinic
6th Sep 20107:00 amPRNHalf-yearly Report
27th Aug 20107:00 amPRNNotice of Interim Results
28th Jun 20107:00 amPRNUpdate on RPL554 and Cough Projects
18th Jun 20104:55 pmPRNGrant of Options
3rd Jun 201012:57 pmPRNResult of AGM
3rd Jun 20107:00 amPRNAGM Statement
4th May 20103:56 pmPRNNotice of AGM
26th Mar 20107:00 amPRNPreliminary Results
20th Jan 20103:52 pmPRNNotice of Interest
14th Jan 20107:00 amPRNNew Year Progress Report
7th Jan 20107:00 amPRNNotice of Interest
6th Jan 201010:37 amPRNApplication for admission of new Ordinary Shares
24th Dec 20099:13 amPRNRESULT OF GENERAL MEETING
18th Dec 20094:16 pmPRNApplication for Admission of New Ordinary Shares
15th Dec 20098:12 amPRNDirectors' Shareholding
9th Dec 20098:04 amPRNPosting of Circular
28th Oct 200911:26 amPRNNotice of interest
11th Sep 20094:57 pmPRNFurther re Board Appointment
11th Sep 20097:03 amPRNBoard Appointment
11th Sep 20097:00 amPRNRPL554 proven safe and effective in patients with asthma
4th Sep 20097:00 amPRNHalf-yearly Report
2nd Sep 20097:00 amPRNChange of Nomad
29th May 20097:00 amPRNTotal Voting Rights
22nd May 200912:01 pmPRNResult of AGM
20th May 20097:00 amPRNClinical Trial Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.